Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Net Debt / (EBITDA-CAPEX)

Aquestive Therapeutics Inc Net Debt / (EBITDA-CAPEX) Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2017 to 2018.
  • Aquestive Therapeutics Inc Net Debt / (EBITDA-CAPEX) for the quarter ending March 03, 2018 was $1m
  • Aquestive Therapeutics Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending March 03, 2018 was $4m
  • Aquestive Therapeutics Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $16m a 16.17% increase of 3m from 2016
  • Aquestive Therapeutics Inc Annual Net Debt / (EBITDA-CAPEX) for 2016 was $14m
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST Net Debt / (EBITDA-CAPEX) Data

03/2018$1m
03/2017$7m

Annual AQST Net Debt / (EBITDA-CAPEX) Data

2017$16m
2016$14m